.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Moodys
Mallinckrodt
Covington
Merck
Cantor Fitzgerald
Farmers Insurance
Julphar
AstraZeneca

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073045

« Back to Dashboard
NDA 073045 describes ALBUTEROL, which is a drug marketed by Genpharm, Ivax Sub Teva Pharms, Pliva, Armstrong Pharms, Mova, Vintage, Copley Pharm, Apotex Inc, Warner Chilcott, Teva, Ucb Inc, Roxane, Watson Labs, Actavis Mid Atlantic, Sun Pharm Inds, Ritedose Corp, Amneal Pharms, Hi Tech Pharma, Teva Pharms, Am Therap, Bausch And Lomb, Sandoz, Mylan Speclt, G And W Labs Inc, Nephron, Sun Pharma Global, Dava Pharms Inc, Landela Pharm, Watson Labs Inc, Vistapharm, Mylan, Wockhardt Eu Operatn, Cipla Ltd, Watson Labs Teva, and Sandoz Inc, and is included in sixty-nine NDAs. It is available from one supplier. Additional details are available on the ALBUTEROL profile page.

The generic ingredient in ALBUTEROL is albuterol sulfate; ipratropium bromide. There are thirty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.

Summary for 073045

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength0.09MG/INH
Approval Date:Aug 19, 1997TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
UBS
Cerilliant
Chinese Patent Office
Johnson and Johnson
Federal Trade Commission
Queensland Health
Baxter
Novartis
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot